New tools to predict how primary microRNAs are processed in cells

Novel Bioinformatics Tools for Quantitative Prediction of Primary MicroRNA Processing

NIH-funded research Yale University · NIH-10698014

This study is looking at how tiny pieces of genetic material called microRNAs are made in our cells and how certain small changes in our DNA can affect this process, which could help us understand some health issues better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University NIH-funded
Lab location1 site (New Haven, United States)
Project IDNIH-10698014 on NIH RePORTER

What this research studies

This research focuses on developing innovative bioinformatics tools to predict how primary microRNA transcripts are processed in human cells. By understanding the role of specific genetic variations, known as single-nucleotide polymorphisms (SNPs), the research aims to uncover how these variations can affect the efficiency of microRNA processing. The project will utilize advanced computational methods to analyze the sequence and structural features of these RNA molecules, providing insights into their regulation and potential implications for human diseases. Patients may benefit from improved understanding of microRNA dysregulation and its links to various health conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with genetic variations that may influence microRNA processing and are affected by diseases related to microRNA dysregulation.

Not a fit: Patients without relevant genetic variations or those not affected by conditions associated with microRNA dysregulation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better predictions of microRNA processing, potentially informing new therapeutic strategies for diseases linked to microRNA dysregulation.

How similar studies have performed: While the approach of developing sequence-based prediction tools is innovative, similar methodologies have shown promise in other areas of genetic research, indicating potential for success.

Where this research is happening

New Haven, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.